HopeStage
Back to all studies
WithdrawnNCT04829669

A Study of Participants With Moderate or Severe Major Depressive Disorder (MDD) Requiring Urgent Symptom Control in a Psychiatric Emergency

Observational studyAges 18–64Depression
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 64 years.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: April 30, 2024
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Janssen-Cilag Ltd.
Sponsor type
Other organization
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
Not clearly listed
Age range
From 18 Years to 64 Years
Official registry ID
NCT04829669
Official title
Show the full official title

Prospective Study to Assess, Outcomes and Healthcare Resource Use of Current Standard of Care for Patients With Moderate or sEvere MDD Requiring Urgent Symptom Control in a Psychiatric Emergency: POWER

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Withdrawn

Locations not listed

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Janssen-Cilag Ltd.

Who can participate?

Listed age limits: 18 years to 64 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies